Serum Meteorin-like protein levels decreased in patients newly diagnosed with type 2 diabetes
Serum Meteorin-like protein levels decreased in patients newly diagnosed with type 2 diabetes
复制标题
DOI：
10.1016/j.diabres.2017.10.005
复制
发表时间：
2018-01-01
影响因子：
5.1
通讯作者：
Ku, Bon Jeong
中科院分区：
文献类型：
--
作者：
Lee, Ju Hee;Kang, Yea Eun;Ku, Bon Jeong
我们分析了人类循环镍纹蛋白样（METRNL）水平。糖尿病患者的血清METRNL水平显著低于非糖尿病患者。血清METRNL水平与血糖水平、胰岛素抵抗呈负相关。二甲双胍治疗12周后未增加血清METRL水平。(C)2017爱思唯尔B.V.保留所有权利。
We analyzed circulating Meteorin-like (METRNL) levels in human. Serum METRNL levels were significantly lower in subjects with diabetes mellitus compared with those without diabetes. Serum METRNL was negatively correlated with the serum glucose level and insulin resistance. Metformin treatment did not increase the serum METRL levels after 12 weeks. (C) 2017 Elsevier B.V. All rights reserved.